Table 2.
Characteristic | Whole Cohort (n = 124) | Mothers of KSHV + Children (n = 81) | Mothers of KHSV− Children (n = 43) |
---|---|---|---|
Mother’s age, y (range) | 30.0 (18–45) | 29.7 | 30.6 |
KSHV seropositive, No. (%) | 86 (69.4) | 54 (66.7) | 32 (74.4) |
CD4 T-cell count (range) | 475.07 (43.75–978.33) | 492.78 (43.75–795.75) | 441.70 (122.13–978.33) |
ART status at enrollment, No. (%) | |||
Ever | 68 (54.8) | 41 (50.6) | 27 (62.8) |
Never | 56 (45.2) | 40 (49.4) | 16 (37.2) |
Years on ART at enrollment (range) | 1.92 (1 mo–14 y) | 1.92 (2 mo–6 y) | 1.69 (1 mo–14 y) |
Abbreviations: ART, antiretroviral therapy; KSHV, Kaposi sarcoma-associated herpesvirus.